Sartorius is expanding its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions GmbH. The lab technology company based in Germany, develops, manufactures and markets solutions for the automated analysis, selection and isolation of cells. With these solutions, ALS aims to enable life science customers to significantly reduce time to result and cost in cell line development and antibody discovery. Other application areas are the development of cell and gene therapeut...